Derek Leishman
Vice President, Translational And Quantitative Toxicology @ Eli Lilly and Company
About Derek Leishman
Derek Leishman serves as the Vice President of Translational and Quantitative Toxicology at Eli Lilly and Company, a position he has held since 2022. He also holds adjunct academic roles at Indiana University School of Medicine and Michigan State University.